Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• The Gleason scoring system is a key predictor of prostate cancer stage and outcomes.
• Modifications by the International Society of Urological Pathology (ISUP) in 2005 aimed to improve correlation between biopsy and radical prostatectomy Gleason scores.
• Accurate stratification of patients based on prognosis is crucial for effective treatment planning.

Purpose of the Study:

• To evaluate pathological and short-term outcomes following the 2005 ISUP Gleason system modifications.
• To assess the potential for dividing the Gleason grading system into prognostically distinct grade groups.
• To determine if a revised grading system can better predict patient outcomes.

Main Methods:

• Analysis of the Johns Hopkins Radical Prostatectomy Database (1982-2011) for 7869 men.
• Utilized multivariable models with preoperative and postoperative variables.
• Prognostic grade groups (Gleason grade ≤ 6; 3 + 4; 4 + 3; 8; 9-10) were analyzed as predictors of biochemical recurrence-free (BFS) survival.

Main Results:

• Significant differences observed in biopsy characteristics across Gleason grade groups.
• Five-year BFS rates varied significantly based on Gleason grade groups at biopsy and radical prostatectomy pathology.
• For biopsy Gleason grades, 5-year BFS rates ranged from 94.6% (≤6) to 34.5% (9-10); for RP pathology, rates ranged from 96.6% to 34.5%.

Conclusions:

• The 2005 ISUP modifications effectively categorize prostate cancer patients by pathology and short-term outcomes.
• A revised reporting system for Gleason grades is needed to better reflect tumor behavior.
• Proposed prognostic grade groups (I-V) offer a clearer reflection of prognosis for physicians and patients.